Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Shao Hui HuangBrian O'SullivanJie SuJolie RingashScott V BratmanJohn KimAli A HosniAndrew BayleyJohn ChoMeredith GiulianiAndrew HopeAnna SpreaficoAaron Richard HansenLillian L SiuRalph GilbertJonathan C IrishDavid GoldsteinJohn R De AlmeidaLi TongWei XuJohn WaldronPublished in: Cancer (2020)
It is proposed that RT-hypo be considered in place of CCRT for HPV+ T1-T3N0-N2c (TNM-7) HNSCCs, HPV- T1-T2N0 HNSCCs, and select stage III HNSCCs during the COVID-19 outbreak.